Connecticut SB 227: AN ACT ESTABLISHING A TASK FORCE TO STUDY OVER-THE-COUNTER DIET PILLS AND SUPPLEMENTS AND PROTECT THE PRIVACY OF PRESCRIBERS OF PRESCRIPTION DRUGS FOR REPRODUCTIVE HEALTH CARE AND GENDER-AFFIRMING HEALTH CARE.

Bill Text

LCO 1 of 6

General Assembly Substitute Bill No. 227
February Session, 2026

AN ACT ESTABLISHING A TASK FORCE TO STUDY OVER-THE-
COUNTER DIET PILLS AND SUPPLEMENTS AND PROTECT THE
PRIVACY OF PRESCRIBERS OF PRESCRIPTION DRUGS FOR
REPRODUCTIVE HEALTH CARE AND GENDER-AFFIRMING HEALTH
CARE.
Be it enacted by the Senate and House of Representatives in General
Assembly convened:

Section 1. (Effective from passage) (a) As used in this section: 1
(1) "Dietary supplement for weight loss or muscle building" means a 2
class of dietary supplement that is labeled, marketed or otherwise 3
represented for the purpose of achieving weight loss or muscle building, 4
but shall not include (A) protein powders, (B) protein drinks, and (C) 5
foods marketed as containing protein unless the protein powder, 6
protein drink or food marketed as containing protein contains an 7
ingredient other than protein which would, considered alone, constitute 8
a dietary supplement for weight loss or muscle building; and 9
(2) "Over-the-counter diet pill" means a class of drugs labeled, 10
marketed or otherwise represented for the purpose of achieving weight 11
loss that are lawfully sold, transferred or furnished over the counter 12
with or without a prescription pursuant to the federal Food, Drug and 13
Cosmetic Act, 21 USC 301 et seq., as amended from time to time, or 14
regulations adopted thereunder. 15

Substitute Bill No. 227

LCO 2 of 6

(b) There is established a task force to study the sale in the state of 16
dietary supplements for weight loss or muscle building and over-the-17
counter diet pills. The task force shall consist of the following members: 18
(1) Two appointed by the speaker of the House of Representatives, 19
one of whom has expertise in the safety of dietary supplements for 20
weight loss or muscle building and one of whom has expertise in the 21
safety of over-the-counter diet pills; 22
(2) Two appointed by the president pro tempore of the Senate; 23
(3) One appointed by the majority leader of the House of 24
Representatives; 25
(4) One appointed by the majority leader of the Senate; 26
(5) One appointed by the minority leader of the House of 27
Representatives; 28
(6) One appointed by the minority leader of the Senate; 29
(7) The Commissioner of Consumer Protection, or the commissioner's 30
designee; 31
(8) The Commissioner of Public Health, or the commissioner's 32
designee; and 33
(9) The executive director of the Commission on Women, Children, 34
Seniors, Equity and Opportunity, who shall serve as chairperson of the 35
task force. 36
(c) Any member of the task force appointed under subdivision (1), 37
(2), (3), (4), (5) or (6) of subsection (b) of this section may be a member 38
of the General Assembly. 39
(d) All initial appointments to the task force shall be made not later 40
than thirty days after the effective date of this section. Any vacancy shall 41
be filled by the appointing authority. 42

Substitute Bill No. 227

LCO 3 of 6

(e) The chairperson of the task force shall schedule the first meeting 43
of the task force, which shall be held not later than sixty days after the 44
effective date of this section. 45
(f) The administrative staff of the joint standing committee of the 46
General Assembly having cognizance of matters relating to general law 47
shall serve as administrative staff of the task force. 48
(g) Not later than January 1, 2027, the task force shall submit a report 49
on its findings and recommendations to the joint standing committee of 50
the General Assembly having cognizance of matters relating to general 51
law, in accordance with the provisions of section 11-4a of the general 52
statutes. The report shall include, but need not be limited to, research 53
related to the safety of dietary supplements for weight loss or muscle 54
building and over-the-counter diet pills by age of users, whether the sale 55
to minors of such supplements or pills should be restricted and best 56
practices in other states for regulation of such supplements or pills. 57
Sec. 2. Section 20-579a of the 2026 supplement to the general statutes 58
is repealed and the following is substituted in lieu thereof (Effective 59
October 1, 2026): 60
(a) As used in this section, "reproductive health care services" and 61
"gender-affirming health care services" have the same meanings as 62
provided in section 52-571m. 63
(b) Notwithstanding any provision of this chapter, the Commissioner 64
of Consumer Protection and the Commission of Pharmacy shall not 65
deny the eligibility of an applicant for a license, permit or registration 66
under this chapter based on pending disciplinary action, an unresolved 67
complaint, [or] the imposition of disciplinary action or other adverse 68
action against the applicant by a duly authorized professional 69
disciplinary agency of another state, the District of Columbia, [or] a 70
commonwealth, territory or possession of the United States or any 71
federal entity that is based solely on the